The medium-term benefits are also likely to be significant for the broader healthcare industry and third sectors involved in commissioning and provision, as well as infrastructure, telecom and IT, administration and outsourcing, and manufacturing of medical devices, pharmaceuticals and diagnostics.
← all excerpts
Sharing the British National Health Service around the world: a self-interested perspective.
1
—
—